SHL Telemedicine Ltd.
Built from real-time financials and updated daily. For a full Analyst Grade with bull/bear case, price targets, and qualitative risk analysis, generate a SMDCF research report →
Companywww.shl-telemedicine.com
SHL Telemedicine Ltd. , together with its subsidiaries, develops and markets personal telemedicine solutions in Israel, Europe, and internationally. The company offers smartheart, a personal mobile 12 lead ECG device that enables the detection of heart attacks; CardioSen'C, a personal cellular-digital 12-lead ECG transmitter device; Cardio'B, a portable device to transmit a 12-lead ECG; and Cardio Beeper 12/12, a hand-held ECG transmitter device for personal use that transmits a full ECG reading to the monitoring center.
- CEO
- Erez Nachtomy
- IPO
- 2016
- Employees
- 402
- HQ
- Tel Aviv, IL
Price Chart
Valuation
- Market Cap
- $280.87M
- P/E
- -1.20
- P/S
- 0.59
- P/B
- 0.86
- EV/EBITDA
- -2.32
- Div Yield
- 0.00%
Profitability
- Gross Margin
- 45.43%
- Op Margin
- -47.19%
- Net Margin
- -49.48%
- ROE
- -49.82%
- ROIC
- -45.76%
Performance & Tape
- 52W High
- $17.15
- 52W Low
- $13.40
- 50D MA
- $17.15
- 200D MA
- $17.15
- Beta
- 0.53
- Avg Volume
- 0
Get TickerSpark's AI analysis on SMDCF
Pro members can request AI-generated analysis on any ticker — technical setup, analyst consensus, earnings watch, insider pulse, financial health, and peer context. Ready in about a minute.
Get Pro Access →30-day money-back guarantee · cancel anytime
Our SMDCF Coverage
We haven't published any research on SMDCF yet
For a full analyst-grade research report — grades, price targets, full financials, chart analysis — generate one on demand.
Generate SMDCF Report →